Skip to main content

Week in Review: January 4–8

Lack of data, disclosures in biomedical literature; hominin interbreeding and immunity; predicting patient responses to the flu vax; fewer off-target effects for engineered Cas9 variant

Written byTracy Vence
| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00

WIKICOMMONS, NICKLAS BILDHAUERJust one of 268 randomly selected biomedical research studies containing empirical data contained a complete protocol, according to an analysis published in PLOS Biology this week (January 4). Examining 441 total papers published between 2000 and 2014, all selected at random, researchers from the Stanford University School of Medicine and the National Cancer Institute also reported on a lack of conflict-of-interest and other disclosures, as well as of instructions for accessing authors’ full data.

“What was most surprising to me was the complete lack of data-sharing and protocol availability,” study coauthor John Ioannidis of Stanford told The Scientist. “That was worse than I would have predicted.”

“It is commendable of the authors to put this study together,” said Arthur Caplan of New York University who was not part of the work. “It’s unique and a useful baseline of transparency, conflict of interest, and reproducibility [in the biomedical literature].”

DANNEMANN ET AL./AJHGWe humans may have our Neanderthal and Denisovan ancestors to thank for some innate immune genes, according to two studies published in The American Journal of Human Genetics this week (January 7). Two independent groups have found genomic evidence to suggest that present-day people inherited versions of several toll-like receptors (TLRs) that recognize pathogens through the interbreeding of human ancestors with Neanderthals and Denisovans.

“At least partially, Neanderthals may have harbored already adaptive mutations, mutations that rendered them more resistant to infections,” said Lluis Quintana-Murci of the Pasteur Institute in ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member?
Add The Scientist as a preferred source on Google

Add The Scientist as a preferred Google source to see more of our trusted coverage.

Meet the Author

Related Topics

Related articles background image
The Scientist Digest cover September 2026
September 2026

Multiplex Microscopy Becomes Easier with Encoded Antibodies

A new system that enables researchers to uniquely tag monoclonal antibodies for use in microscopy could help simplify complex imaging studies.

View this Issue
Rethinking ALS Biomarkers: From Discovery to Clinical Impact

Rethinking ALS Biomarkers: From Discovery to Clinical Impact

Alamar Biosciences logo
Best Practices for qPCR Assay Design and Optimization

Best Practices for qPCR Assay Design and Optimization

Bio-Rad
Beyond the Basics: Strategies for Single-Cell and Spatial Transcriptomics Analysis

Beyond the Basics: Strategies for Single-Cell and Spatial Transcriptomics Analysis

bioxcell
Scientist reviewing cellular and molecular data on a computer in a laboratory.

Building Translation-Ready Biomarkers with Connected Workflows

Danaher Logo

Products

Closeup image of a multi channel pipette dispensing pink liquid into a 96-well plate.

The ASSIST PLUS pipetting robot for affordable workflow automation

Integra Logo
Single cells in suspension

Rapidly isolate primary cells and make uniform single-cell suspensions with Corning® Cell Strainers

Corning logo
Abstract image representing cell membranes linked together.

CellBrite® Steady Membrane Stain: Cell surface staining built for real-time imaging

Biotium
sino biological logo

Monod Bio Licenses AI-designed Protein Technologies to SignalChem Biotech for Custom Discovery Assays